Holen Sie sich die Stockscreener-App
178.45
0.03%
0.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$178.39
Offen:
$178.48
24-Stunden-Volumen:
548.89K
Relative Volume:
0.34
Marktkapitalisierung:
$9.34B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$207.70M
KGV:
-64.34
EPS:
-2.7734
Netto-Cashflow:
$193.10M
1W Leistung:
-0.01%
1M Leistung:
+0.12%
6M Leistung:
+21.39%
1J Leistung:
+17.29%
1-Tages-Spanne:
$178.25
$178.50
1-Wochen-Bereich:
$178.25
$178.53
52-Wochen-Spanne:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
178.45 | 9.34B | 1.53B | 207.70M | 193.10M | -2.7734 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Masimo Corporation (NASDAQ:MASI) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
MSN Money - MSN
Denon Receiver: Premium Audio Powerhouse Faces Streaming Market Shifts - AD HOC NEWS
13,196 Shares in Masimo Corporation $MASI Bought by Lecap Asset Management Ltd. - MarketBeat
Masimo's Appeal Rejection, M5 Chip Push, China Smartphone Growth, Foldable iPhone: This Week In Appleverse - Benzinga
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Apple Scores Key Win As Trade Commission Rejects Masimo's Bid To Reinstate Apple Watch Import Ban - Benzinga
Apple secures a win as US trade tribunal rejects Masimo’s bid for new watch ban - Investing.com
Apple secures a win as US trade tribunal rejects Masimo’s bid for new watch ban By Investing.com - Investing.com South Africa
Apple Clears Major Legal Hurdle After U.S. Trade Tribunal Shuts Down Masimo’s Latest Watch Ban Attempt - Stocktwits
Apple defeats bid for new Apple Watch import ban at US trade tribunal - Reuters
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
Masimo (MASI) Secures $100M Contract for Patient Monitoring Equi - GuruFocus
Masimo (MASI) Secures $100M Contract Modification for Patient Mo - GuruFocus
Denon Receiver: Premium Audio Power Faces Streaming and Smart Home Shifts - AD HOC NEWS
Denon Receiver: Between Audio Innovation and Ownership Shifts, Market Position Strengthens - AD HOC NEWS
Massachusetts Financial Services Co. MA Boosts Stock Position in Masimo Corporation $MASI - MarketBeat
Published on: 2026-04-12 06:39:28 - baoquankhu1.vn
Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Masimo Buyout By Danaher Faces Shareholder Scrutiny On Deal Value - Yahoo Finance
Market news - investments.halifax.co.uk
Masimo stock price target raised to $180 by Jefferies on Danaher deal - Investing.com UK
31,641 Shares in Masimo Corporation $MASI Acquired by Tudor Investment Corp ET AL - MarketBeat
Masimo Corp Stock Historical Valuations | BSP:M2AS34 - GuruFocus
Masimo Corp Stock Intrinsic Values | BSP:M2AS34 - GuruFocus
Masimo Corp (BSP:M2AS34) Competitors 2026 - GuruFocus
Masimo Corp (BSP:M2AS34) Valuation: Fairly Valued - GuruFocus
Masimo Corp (BSP:M2AS34) Dividend - GuruFocus
Masimo Corp (BSP:M2AS34) Stock Price & 30 Year Financial Data - GuruFocus
Masimo Corp Stock Operating Data - GuruFocus
Masimo Corp Stock Baskets | BSP:M2AS34 - GuruFocus
Masimo Corp Stock Warning Signs | BSP:M2AS34 - GuruFocus
Masimo Corp (BSP:M2AS34) Stock Price, Trades & News - GuruFocus
Masimo Corp (BSP:M2AS34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Masimo Corp (BSP:M2AS34) Stock News, Headlines & Updates - GuruFocus
Masimo Corp (BSP:M2AS34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Who's Buying or Selling Masimo Corp (BSP:M2AS34) Stock Today? - GuruFocus
Wealth Enhancement Advisory Services LLC Raises Stake in Masimo Corporation $MASI - MarketBeat
SG Americas Securities LLC Increases Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo Corporation (MASI) stock price, news, quote and history - Yahoo Finance UK
Masimo Corporation (MASI) Stock forecasts - Yahoo Finance UK
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN - Benzinga
Masimo (MASI) agrees to $180 cash takeover by Danaher; vote set May 1, 2026 - Stock Titan
Quinn Emanuel disqualified in Masimo board dispute - Daily Journal
Quinn Emanuel Disqualified from Masimo Board Fight with Founder - National Today
Quinn Emanuel Disqualified From Masimo Board Fight With Founder - Bloomberg Law News
Masimo Corp Stock: Innovative Medical Tech Leader with Strong Growth Potential for North American In - AD HOC NEWS
Assenagon Asset Management S.A. Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal - AD HOC NEWS
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
The Vanguard Group discloses 0 shares in Masimo Corp (NASDAQ: MASI) - Stock Titan
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):